- Retraction Note
- Open Access
Retraction Note: metastatic collecting duct carcinoma of the kidney treated with Sunitinib
https://doi.org/10.1186/1477-7819-9-136
© Tazi et al; licensee BioMed Central Ltd. 2011
- Received: 21 October 2011
- Accepted: 24 October 2011
- Published: 24 October 2011
The original article was published in World Journal of Surgical Oncology 2011 9:73
Retraction
The authors have retracted this article [1] as it contains large portions of text and figures that have been duplicated from another article previously published in the International Journal of Clinical Oncology[2]. Lead author Dr Tazi accepts full responsibly for the duplication and would like to apologise to the co-authors, Editors and readers as well as the authors of the original article.
Notes
Authors’ Affiliations
References
- Tazi EM, Essadi M, Tazi MF, Ahellal Y, M'rabti H, Errihani H: Metastatic collecting duct carcinoma of the kidney treated with Sunitinib. World Journal of Surgical Oncology. 2011, 9: 73-10.1186/1477-7819-9-73.PubMed CentralView ArticlePubMedGoogle Scholar
- Miyake H, Haraguchi T, Takenaka A, Fujisawa M: Metastatic collecting duct carcinoma of the kidney responded to sunitinib. International Journal of Clinical Oncology. 2011, 16: 153-155. 10.1007/s10147-010-0116-z.View ArticlePubMedGoogle Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
